LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 16.73 | 770.25 | 1055 | 1664 | 0.6338 | 0.3271 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 18.95 | 770.25 | 1308 | 1832 | 0.7138 | 0.5273 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 18.95 | 770.25 | 1082 | 1832 | 0.5905 | 0.3123 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 21.17 | 770.25 | 1322 | 2008 | 0.6582 | 0.4780 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 21.17 | 770.25 | 1035 | 2008 | 0.5153 | 0.2382 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 23.39 | 770.25 | 1224 | 2244 | 0.5453 | 0.3501 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 23.39 | 770.25 | 1081 | 2244 | 0.4816 | 0.2457 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 25.62 | 770.25 | 1324 | 2514 | 0.5265 | 0.3735 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 25.62 | 770.25 | 1092 | 2514 | 0.4342 | 0.2269 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 27.84 | 770.25 | 1332 | 2833 | 0.4700 | 0.3384 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 27.84 | 770.25 | 964 | 2833 | 0.3402 | 0.1268 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 30.06 | 770.25 | 1324 | 3106 | 0.4263 | 0.3090 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 30.06 | 770.25 | 1061 | 3106 | 0.3416 | 0.1726 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 32.28 | 770.25 | 1347 | 3392 | 0.3970 | 0.2986 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 32.28 | 770.25 | 1010 | 3392 | 0.2977 | 0.1351 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 34.50 | 770.25 | 1257 | 3712 | 0.3386 | 0.2409 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 34.50 | 770.25 | 1003 | 3712 | 0.2702 | 0.1234 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.73 | 770.25 | 1286 | 4086 | 0.3147 | 0.2373 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.73 | 770.25 | 991 | 4086 | 0.2425 | 0.1104 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 38.95 | 770.25 | 1296 | 4543 | 0.2852 | 0.2253 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 38.95 | 770.25 | 1028 | 4543 | 0.2262 | 0.1193 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 41.17 | 770.25 | 1319 | 5010 | 0.2632 | 0.2203 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 41.17 | 770.25 | 1031 | 5010 | 0.2058 | 0.1140 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 43.39 | 770.25 | 1367 | 5404 | 0.2529 | 0.2264 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 43.39 | 770.25 | 1131 | 5404 | 0.2093 | 0.1465 | MN20160304_L02 | G16 |